Literature DB >> 25772075

A case report of bilateral paramedian thalamic and occult midbrain infarctions without disturbance of consciousness.

Yuki Sakamoto1, Seiji Okubo, Takuya Kanamaru, Kentaro Suzuki, Kazumi Kimura.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25772075     DOI: 10.1007/s10072-015-2128-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  7 in total

1.  Bilateral thalamic infarction. Clinical, etiological and MRI correlates.

Authors:  E Kumral; D Evyapan; K Balkir; S Kutluhan
Journal:  Acta Neurol Scand       Date:  2001-01       Impact factor: 3.209

2.  The syndrome of combined polar and paramedian thalamic infarction.

Authors:  Fabienne Perren; Stephanie Clarke; Julien Bogousslavsky
Journal:  Arch Neurol       Date:  2005-08

3.  Neuropsychological profile of bilateral paramedian infarctions: three cases.

Authors:  M Jodar; P Martos; S Fernández; D Canovas; A Rovira
Journal:  Neurocase       Date:  2011-08       Impact factor: 0.881

4.  The anatomy of the arterial supply of the human thalamus and its use for the interpretation of the thalamic vascular pathology.

Authors:  G Percheron
Journal:  Z Neurol       Date:  1973-08-29

5.  Do thalamic lesions really cause vertical gaze palsies?

Authors:  R M Siatkowski; N J Schatz; T P Sellitti; S L Galetta; J S Glaser
Journal:  J Clin Neuroophthalmol       Date:  1993-09

6.  Bilateral paramedian thalamic artery infarcts: report of 10 cases.

Authors:  Pedro Enrique Jiménez Caballero
Journal:  J Stroke Cerebrovasc Dis       Date:  2010 Jul-Aug       Impact factor: 2.136

7.  Vertical gaze palsies from medial thalamic infarctions without midbrain involvement.

Authors:  J M Clark; G W Albers
Journal:  Stroke       Date:  1995-08       Impact factor: 7.914

  7 in total
  1 in total

Review 1.  Clinical Features of Thalamic Stroke.

Authors:  Xiang Yan Chen; Qiaoshu Wang; Xin Wang; Ka Sing Wong
Journal:  Curr Treat Options Neurol       Date:  2017-02       Impact factor: 3.598

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.